Indacaterol: a new once daily long-acting beta(2) adrenoceptor agonist

por Beeh, Kai M, Beier, Jutta
Publicado 2010

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol

por Beier, Jutta, Beeh, Kai M
Publicado 2011

Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily...

por Plate, Tanja, Friedrich, Felix W, Beier, Jutta
Publicado 2020

Clinical trial design in chronic obstructive pulmonary disease: current perspectives and considerations with regard to blinding of tiotropium

por Beeh, Kai-Michael, Beier, Jutta, Donohue, James F
Publicado 2012

Effect of ELOM-080 on exacerbations and symptoms in COPD patients with a chronic bronchitis phenotype – a post-hoc analysis of a randomized, double-blind, placebo-controlled clinic...

por Beeh, Kai-Michael, Beier, Jutta, Candler, Henning, Wittig, Thomas
Publicado 2016

Improvement in 24-hour bronchodilation and symptom control with aclidinium bromide versus tiotropium and placebo in symptomatic patients with COPD: post hoc analysis of a Phase III...

por Beier, Jutta, Mroz, Robert, Kirsten, Anne-Marie, Chuecos, Ferran, Gil, Esther Garcia
Publicado 2017

Efficacy, safety, and tolerability of once‐daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7‐day, crossover study

por Beier, Jutta, Fuhr, Rainard, Seoane, Beatriz, Massana, Eric, de Miquel, Gonzalo, Pujol, Helena, Ruiz, Sandrine
Publicado 2017

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Ran...

por Beier, Jutta, Kirsten, Anne-Marie, Mróz, Robert, Segarra, Rosa, Chuecos, Ferran, Caracta, Cynthia, Gil, Esther Garcia
Publicado 2013

Safety and efficacy of dual therapy with GSK233705 and salmeterol versus monotherapy with salmeterol, tiotropium, or placebo in a crossover pilot study in partially reversible COPD...

por Beier, Jutta, van Noord, Jan, Deans, Amanda, Brooks, Jean, Maden, Claire, Baggen, Suus, Mehta, Rashmi, Cahn, Anthony
Publicado 2012

Abediterol, a novel long-acting β(2)-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patient...

por Beier, Jutta, Pujol, Helena, Seoane, Beatriz, Jimenez, Eulalia, Astbury, Carol, Massana, Eric, Ruiz, Sandrine, de Miquel, Gonzalo
Publicado 2016

Lung function improvements following inhaled indacaterol/glycopyrronium/mometasone furoate are independent of dosing time in asthma patients: a randomised trial

por Beier, Jutta, Watz, Henrik, Diamant, Zuzana, Hohlfeld, Jens M., Singh, Dave, Pinot, Pascale, Jones, Ieuan, Tillmann, Hanns-Christian
Publicado 2021

Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controll...

por Brown, Mary N., Fuhr, Rainard, Beier, Jutta, Su, Hong-Lin, Chen, Yingxue, Forsman, Henrik, Hamrén, Ulrika Wählby, Jackson, Helen, Aggarwal, Ajay
Publicado 2019

Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma

por Erpenbeck, Veit J., Popov, Todor A., Miller, David, Weinstein, Steven F., Spector, Sheldon, Magnusson, Baldur, Osuntokun, Wande, Goldsmith, Paul, Weiss, Markus, Beier, Jutta
Publicado 2016

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-...

por Beeh, Kai Michael, Kirsten, Anne-Marie, Tanase, Ana-Maria, Richard, Alexia, Cao, Weihua, Hederer, Bettina, Beier, Jutta, Kornmann, Oliver, van Zyl-Smit, Richard N
Publicado 2018

A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study

por Chapman, Kenneth R, Beeh, Kai-Michael, Beier, Jutta, Bateman, Eric D, D’Urzo, Anthony, Nutbrown, Robert, Henley, Michelle, Chen, Hungta, Overend, Tim, D’Andrea, Peter
Publicado 2014

Longitudinal measurement of airway inflammation over one year in children and adults with intermittent asthma

por Pedersen, Frauke, Holz, Olaf, Kanniess, Frank, Zielen, Stefan, Schulze, Johannes, Gillissen, Adrian, von Berg, Andrea, Berdel, Dietrich, Beier, Jutta, Beeh, Kai, Schnoor, Maike, Magnussen, Helgo
Publicado 2014

Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over stud...

por Watz, Henrik, Hohlfeld, Jens M., Singh, Dave, Beier, Jutta, Diamant, Zuzana, Liu, Jinming, Hua, Shucheng, Abd-Elaziz, Khalid, Pinot, Pascale, Jones, Ieuan, Tillmann, Hanns-Christian
Publicado 2020

The novel bronchodilator navafenterol: a phase 2a, multicentre, randomised, double-blind, placebo-controlled crossover trial in COPD

por Singh, Dave, Beier, Jutta, Astbury, Carol, Belvisi, Maria G., Da Silva, Carla A., Jauhiainen, Alexandra, Jimenez, Eulalia, Lei, Alejhandra, Necander, Sofia, Smith, Jaclyn A., Wählby Hamrén, Ulrika, Xin, Wenjing, Psallidas, Ioannis
Publicado 2022